For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
In our recent article, we compared the advantages and disadvantages of different antibody validation techniques to help you choose the right method for your experiment. Though each technique highlights a unique type of validation, knockout validation gives the most precise answer to the question of specificity.
Abcam knockout validates its antibodies using the extensive library of knockout cell lines available from Horizon Discovery. We are utilizing their human knockout cell lines generated from haploid cellular models using a CRISPR/Cas9 genome-editing system to bring you a range of premium knockout validated antibodies. This type of knockout cell line provides a complete loss-of-function phenotype from a single allele knockout and eliminates any masking of the knockout from a second allele seen in diploid cell models (1, 2, 3).
Fluorescent western blotting using anti-Cdk4 antibody [EPR4513] (ab108357) at 1/1000 dilution. Lane 1: Wild-type HAP1 cell lysate, lane 2: Human Cdk4 Knockout cell lysate. Target band at 34 kDa. Loading control band using anti-beta Actin (ab8227) at 42 kDa.
Following our stringent quality control and validation processes, our antibodies are tested in both knockout and wild type samples using a western blotting based assay. We are in the process of expanding our knockout based antibody validation to other types of assays (i.e. ICC, IHC, Flow Cyt).